StockData
Summit Therapeutics Inc. logo

Summit Therapeutics Inc. (SMMT) stock

SMMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$10.50−0.17 (-1.59%)

Close on Nov 18, 2026Market cap $8.38BP/E –Yield –

Summit Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Summit Therapeutics's total debt was $0 at Dec 31, 2024. For fiscal 2024 it was $0, down 100.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$0-100.0%
FY2023Dec 31, 2023$100.00M-79.8%
FY2022Dec 31, 2022$494.54M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2024CQ4 2024Dec 31, 2024$0-100.0%
Q3 FY2024CQ3 2024Sep 30, 2024$0–
Q2 FY2024CQ2 2024Jun 30, 2024$0-100.0%
Q1 FY2024CQ1 2024Mar 31, 2024$100.00M-79.8%
Q4 FY2023CQ4 2023Dec 31, 2023$100.00M–
Q3 FY2023CQ3 2023Sep 30, 2023$0–
Q2 FY2023CQ2 2023Jun 30, 2023$100.00M–
Q4 FY2022CQ4 2022Dec 31, 2022$494.54M–

More Summit Therapeutics figures

See a number that looks wrong?